CHICAGO — Patients with nonalcoholic fatty liver disease had worse COVID-19-related outcomes compared with infected individuals without NAFLD, according to data presented at Digestive Disease Week.
“The COVID-19 pandemic is one of the most significant global public health crises in recent history,” Khaled AlsabbaghAlchirazi, MD, clinical assistant professor of medicine at Cleveland Clinic, told Healio. “Obesity and other metabolic factors can exacerbate the severity of COVID-19. NAFLD is the most common chronic liver condition in the United States and is considered a hepatic manifestation of the metabolic syndrome.”